Krall continued, In mid-October, we initiated an aggressive and proactive new business strategy by signing Richmont Sciences to lead PURE ™s direct sales and marketing efforts for our existing SDC-based disinfectant. As part of its initial marketing efforts, John Rochon and his team have already held meetings with many potential new customers and have created a heightened awareness of SDC-based disinfectant products on a national level in multiple markets in anticipation of the registration of the IV-7 Ultimate Germ Defense?„? product and their subsequent full-scale sales launch. Richmont ™s commitment, energy, passion and invaluable expertise is coinciding with a recent and rising urgency in the marketplace for a responsible and effective weapon against the ever increasing threat of dangerous pathogens in our everyday lives. State registrations for IV-7 should be finalized within the next 90 days, and we expect Richmont to hit the ground running. Richmont will also market the disinfectant/food contact sanitizer product when it becomes available.

Existing distributors of SDC-based hard surface disinfectant are also gaining traction in their respective markets. Yesterday, BioTech Medical launched its public health information website, www.touchsurfaces. Dr. Bob Arnot, physician and popular television medical correspondent, serves as the chief medical educator for the campaign, which recommends BioTech ™s SDC product, SpectraSan 24TM hard surface disinfectant, as a powerful weapon in eradicating H1N1, MRSA, VRE, Norovirus and other dangerous pathogens commonly spread on hard surfaces.

Krall concluded, Our medical and pharmaceutical projects are also building momentum as FTA works with leading researchers and hospitals, including its partner, Cleveland Clinic, to establish and conduct trials for a diverse set of SDC-based products. We anticipate announcing clinical progress in the coming quarters.